Speakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with […]

Kevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the Harvard Infectious Diseases Consortium. For more information, visit harvardamr.com   

Kevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem".  Outterson will also be participating on a panel titled "Analyzing the potential impact of current commercial and “pull” initiatives" on November 7th. Karen Gallant, Deputy Executive Director of CARB-X, will be […]

This webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the […]

Presenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is […]

Kevin Outterson, Executive Director of CARB-X, is participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be […]

Presenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on […]

In this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give an overview of recent advances in AMR diagnostics development. He […]

Speakers include Kevin Outterson, Executive Director of CARB-X. The rise of antimicrobial resistance and the corresponding lack of novel antibiotic development impacts the ability of physicians to provide appropriate care […]

Moderator: Kevin Outterson, Executive Director, CARB-X, Professor of Law, Boston University Panel: Lars Rebien Sorensen, Chairman of the Novo Nordisk Foundation and Novo Holdings Jeremy Farrar, Director, Wellcome Trust Dr. Malin Grape, Head of Antibiotics Unit, The Public Health Agency of Sweden Thomas Cueni, Director General, IFPMA Jayasree K. Iyer, Executive Director, Access to Medicine Foundation […]